Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 5
1990 1
1992 5
1993 2
1996 3
1997 1
2000 7
2002 1
2004 1
2005 11
2006 8
2007 1
2009 4
2010 5
2012 6
2013 8
2014 1
2015 12
2016 8
2017 9
2018 15
2019 41
2020 16
2021 17
2022 8
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
de Alwis R, Gan ES, Chen S, Leong YS, Tan HC, Zhang SL, Yau C, Low JGH, Kalimuddin S, Matsuda D, Allen EC, Hartman P, Park KJ, Alayyoubi M, Bhaskaran H, Dukanovic A, Bao Y, Clemente B, Vega J, Roberts S, Gonzalez JA, Sablad M, Yelin R, Taylor W, Tachikawa K, Parker S, Karmali P, Davis J, Sullivan BM, Sullivan SM, Hughes SG, Chivukula P, Ooi EE. de Alwis R, et al. Mol Ther. 2021 Jun 2;29(6):1970-1983. doi: 10.1016/j.ymthe.2021.04.001. Epub 2021 Apr 5. Mol Ther. 2021. PMID: 33823303 Free PMC article.
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients.
Vissers MFJM, Heuberger JAAC, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, Harris J, Tsai RM, Cruz-Herranz A, Huang F, Tong V, Erickson R, Zhu Y, Scearce-Levie K, Hsiao-Nakamoto J, Tang X, Chang M, Fox BM, Estrada AA, Pomponio RJ, Alonso-Alonso M, Zilberstein M, Atassi N, Troyer MD, Ho C. Vissers MFJM, et al. Clin Transl Sci. 2022 Aug;15(8):2010-2023. doi: 10.1111/cts.13317. Epub 2022 Jun 1. Clin Transl Sci. 2022. PMID: 35649245 Free PMC article. Clinical Trial.
Insulin in ramadan.
Kalra S, Jawad F. Kalra S, et al. J Pak Med Assoc. 2015 May;65(5 Suppl 1):S44-6. J Pak Med Assoc. 2015. PMID: 26013785
Collaborations between Clinical Pharmacologists in Japan and in the United States - Report from the IQ CPLG and JPMA CPTF Meeting in Tokyo, Japan.
Zhu T, Kayama M, Girish S, Sinha V, Bello A, Kawaguchi A, Czerniak R, Nagao L. Zhu T, et al. Clin Transl Sci. 2021 Jan;14(1):102-105. doi: 10.1111/cts.12853. Epub 2020 Sep 24. Clin Transl Sci. 2021. PMID: 32969589 Free PMC article. Review.
The meeting was also attended by Japan Pharmaceutical Manufactures Association (JPMA) Clinical Pharmacology Task Force (CPTF) members. Overall, nearly 30 clinical pharmacologists representing 14 companies attended the event. ...In a number of break-out sessions, participan …
The meeting was also attended by Japan Pharmaceutical Manufactures Association (JPMA) Clinical Pharmacology Task Force (CPTF) members …
[Establishment and International Harmonization of Photosafety Testing Strategy].
Onoue S. Onoue S. Yakugaku Zasshi. 2021;141(6):807-812. doi: 10.1248/yakushi.20-00217-4. Yakugaku Zasshi. 2021. PMID: 34078785 Free article. Review. Japanese.
The validation study for the ROS assay has been being carried out by the Japan Pharmaceutical Manufacturers Association (JPMA), supervised by the Japanese Center for the Validation of Alternative Methods (JaCVAM). ...
The validation study for the ROS assay has been being carried out by the Japan Pharmaceutical Manufacturers Association (JPMA), super …
Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in 2017: A Cross-sectional Analysis.
Murayama A, Kamamoto S, Saito H, Yamashita E, Suzuki Y, Tanimoto T, Ozieranski P, Ozaki A. Murayama A, et al. Int J Health Policy Manag. 2023;12:7621. doi: 10.34172/ijhpm.2023.7621. Epub 2023 Aug 21. Int J Health Policy Manag. 2023. PMID: 38618821 Free PMC article. Review.
METHODS: This study employed a cross-sectional design to analyse the extent and distribution of all scholarship donations made by all 73 pharmaceutical companies belonging to the Japan Pharmaceutical Manufacturers Association (JPMA) to healthcare institutions in 2017. Data …
METHODS: This study employed a cross-sectional design to analyse the extent and distribution of all scholarship donations made by all 73 pha …
205 results